CellTrans

CellTrans's mission is to develop, manufacture, and commercialize FDA-approved cell therapies and novel bioengineering technologies for the treatment of diabetes and other endocrine disorders. Its vision is to improve the human condition through functional treatments via bioengineered cell transplantation.